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Perﬂuorooctanoic acid (PFOA) is a perﬂuorinated compound ubiquitously detected in the environment,
including wildlife and humans. Despite the available information, research on the cytotoxicity of PFOA
in non-tumoral mammalian cells is relatively limited.
In this work, two in vitro toxicity systems were employed to provide further insight into the cytotoxic and
mutagenic potential of PFOA. The cytotoxicity of the chemical towards Vero cells was assessed using bio-
chemical and morphological parameters, while mutagenicity was evaluated according to Ames test. High
doses of PFOA cause oxidative stress in Vero cells, that was closely linked to cell cycle arrest at the G1
phase and induction of apoptosis. Our results corroborate previous ﬁndings in human tumoral cells
and suggest that the mode of action of this perﬂuorinated compound is not a peculiarity among mamma-
lian cell types. On the other hand, the compound was not mutagenic in the Ames test, using four strains of
Salmonella typhimurium in the presence or absence of rat S9 metabolic activation system.
 2008 Elsevier Ltd. All rights reserved.1. Introduction
Perﬂuorinated compounds (PFCs) are just one of many groups of
hazardous pollutants building up in biota and water on a global
scale (Prevedouros et al., 2006). These chemicals are widely used
in a very broad range of industrial, commercial and consumer prod-
ucts, because of their non-stick and water repellent properties. The
unusual physico-chemical features of PFCs, so effective in these
products, also make them extremely resistant to degradation, thus
raising threats to both environment and human health (EPA, 2002).
Recent biomonitoring studies reveal the prevalence of PFCs lev-
els, particularly perﬂuorooctanoic acid (PFOA), in wildlife tissues
from all over the world (Kannan et al., 2002) as well as in the ser-
um of human general populations (Olsen et al., 2005). It is worth
mentioning that extensive investigations do not suggest consistent
association between PFOA exposure and signiﬁcant human health
problems (Butenhoff et al., 2004), although this compound is con-
sidered a ‘‘likely” human carcinogen (EPA, 2002).
Most toxicological studies have focused primarily on analyzing
the effects of perﬂuorooctanoic acid in experimental animals and
corresponding publications have been recently reviewed (Lau
et al., 2007). Estimation of toxicity in rodents revealed that PFOA
is readily absorbed but not metabolized (Kuslikis et al., 1992)
and preferentially accumulated in the liver (Kudo et al., 2006).
The developmental and postnatal toxicity of PFOA has also beenll rights reserved.
+34 914978344.
en).examined in mice (Lau et al., 2006) and rats (Hinderliter et al.,
2005), although dissimilar proﬁles were observed due to pharma-
cokinetic differences between these two rodent species (Lau et al.,
2006). In addition, PFOA is known to suppress immune system
function in mice (Yang et al., 2002) and cause tumors in rodents
(EPA, 2002).
On the other hand, cytotoxicity proﬁles for ﬁsh (Oakes et al.,
2004) and invertebrates (Sanderson et al., 2004) indicate that, at
environmental levels, PFOA elicited only moderate effects in most
organisms.
Comparatively, few in vitro studies have been conducted to
evaluate the cellular mechanisms underlying the toxicity of this
perﬂuorinated compound in mammalian cells. Recent results ob-
tained in rat tumor cell lines suggest that PFOA is not acutely toxic
at the cellular level (Mulkiewicz et al., 2007). Even so, it has been
reported that this compound perturbs the cell cycle, induces apop-
tosis and exerts genotoxic effects in the human hepatoma cell line
HepG2 such as DNA breaks (Panaretakis et al., 2001; Shabalina
et al., 1999) and micronuclei (Yao and Zhong, 2005). At present,
there are no similar data available in non-tumoral mammalian
cells, so renewed efforts are needed to better understand the toxic
and carcinogenic effects of PFOA.
In previous studies from this laboratory it has been shown that
the monkey kidney-derived cell line Vero, is a useful tool for study-
ing the cellular effects induced by chemicals that are currently
found in the environment (Fernández Freire et al., 2005; Labrador
et al., 2007; Pérez Martín et al., 2008). Thus, the present work was
designed to analyze the cytotoxic potential of PFOA in mammalian
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proﬁle of this ubiquitous pollutant. The evaluation was combined
with the Salmonella typhimurium/microsome test, predictive of
integral mutagenic/carcinogenic activity.
Our results, although simpliﬁed with respect to the in vivo situ-
ations, indicate that PFOA was negative in the Ames test and pro-
duces moderate toxicity in normal mammalian cells.2. Materials and methods
2.1. Cell culture and PFOA treatments
Vero cells were grown at 37 C in 25 cm2 ﬂasks (Falcon, Becton
Dickinson, USA) under a 5% CO2 humidiﬁed atmosphere, using Dul-
becco’s modiﬁed Eagle’s medium (DMEM), supplemented with 5%
fetal calf serum, 100 U/ml penicillin, 100 mg/ml streptomycin and
2 mM L-glutamine (all from Bio-Whittaker, Belgium). Cells were
seeded at a density of 105 cells/ml in 25 cm2 ﬂasks or into 24-well
plates for quantitative analysis and into 6-well plates, containing a
sterile glass coverslip in each well, for morphological studies.
After removing cell culture medium and washing in phosphate
buffered saline (PBS), exponentially growing cells were incubated
for 24 h with new medium containing serial dilutions of PFOA.
Stock solutions of 101 M perﬂuoorooctanoic acid (Sigma, USA),
were prepared in dimethylsulphoxide (DMSO) and maintained in
darkness at room temperature. The working solutions, ranging
from 10 to 500 lM (4–200 lg/ml), were prepared fresh in different
media according to each experimental system, and sterilized by ﬁl-
tration through a 0.22 lm Millipore ﬁlter. Maximum DMSO con-
centration in medium was 0.5% including the control groups.
2.2. Cytotoxicity assessment
Two colorimetric assays were used to determine the cytotoxic-
ity of PFOA. The tetrazolium MTT test was performed according to
the method of Mosmann (1983). Brieﬂy, following treatments with
PFOA, cell cultures were incubated for 2 h with MTT (Sigma) in
DMEM, at a ﬁnal concentration of 0.5 mg/ml. The medium was re-
placed with DMSO for formazan solubilization, before reading
absorbance. A second assay was the quantiﬁcation of total protein
content (TPC), according to the method of Bradford (1976) using
Coomassie Brilliant Blue G-250 reagent (Bio-Rad, USA) and bovine
serum albumin (Sigma) as standard. Absorbances were measured
at 570 and 595 nm, respectively, using a Spectraﬂuor microplate
reader (Tecan, Austria).
2.3. Morphological characterization of mitochondria
For evaluation of mitochondria integrity, control and PFOA-
treated cells were incubated 8 min in complete culture medium
with 6.5 lg/ml rhodamine 123 (Sigma). After a thorough wash with
PBS they were immediately observed under blue exciting light, as a
wet preparation.
Microscopic observations were carried out using an Olympus
BX-61 epiﬂuorescence microscope (Tokyo, Japan), equipped with
an HBO 100W mercury lamp and ultraviolet (UV, 365 nm), blue
(450–490 nm) and green (546 nm) excitation ﬁlters. The images
were acquired with a CCD camera Olympus DP-70 and processed
using the software Olympus DP controller 1.1.1.65 and Adobe
Photoshop 9.0 (Adobe Systems Inc.).
2.4. Cell cycle analysis
To analyze cell cycle distribution, Vero cells treated for 24 h
with 50, 200 and 500 lM PFOA, were collected by trypsinisationand ﬁxed with ice-cold 70% methanol. After gentle washing with
PBS, the cells were resuspended in 1 ml of staining buffer consist-
ing of 0.1% sodium citrate, 50 lg/ml propidium iodide and 50 lg/ml
RNase A (all Sigma), and incubated in the dark for 30 min. Nuclei
were then analyzed using a Coulter Epics XL-MCL ﬂow cytometer
with the Expo 32 ADC software (Beckman Coulter Inc., USA).
2.5. Quantiﬁcation of apoptotic cells
Nuclear integrity was visualized by DNA staining with the ﬂuo-
rescent dye Hoechst 33258, as previously described (Fernández
Freire et al., 2005). Brieﬂy, after treatment with PFOA, the detached
cells recovered in the supernatant and the adherent cells recovered
by trypsinization, were pooled and centrifuged (10 min at
1200 rpm). The pellets were re suspended in 100 ll cold methanol
and 10 ll (1 mg/ml) Hoechst 33258 and kept in the dark at 20 C
until used. An aliquot of each cell suspension was taken for count-
ing, the numbers of condensed or fragmented nuclei versus normal
nuclei, in at least 2000 cells for each treatment.
2.6. Detection of reactive oxygen species (ROS)
In order to measure the intracellular ROS level after PFOA treat-
ments we used the 2070-dichloroﬂuorescein diacetate (DCFH-DA)
method as described by Wang and Joseph (1999). In brief, cells
were loaded with 100 lM DCFH-DA for 30 min and then washed
with sterile PBS. DCFH-DA is non-ﬂuorescent until hydrolyzed by
intracellular esterases and readily oxidized to the highly ﬂuores-
cent DCF in the presence of reactive oxygen species. Fluorescence
was monitored on a Spectraﬂuor microplate reader with excitation
and emission wavelengths of 488 and 530 nm, respectively. H2O2
(500 lM, 30 min) was used as positive control. Results were nor-
malized, for differences in cell number, by quantitation of cell pro-
tein according to Bradford assay and expressed as arbitrary
ﬂuorescence units (AFU) per percentage of protein, with respect
to the untreated control.
2.7. Bacterial reversion assay
The test was performed using the classical plate incorporation
method according to Maron and Ames (1983). Brieﬂy, a set of tes-
ter strains of S. typhimurium that react preferentially with GC base
pairs (TA98, TA100) or AT base pairs (TA102, TA104) were grown
for 14 h in Difco bacto nutrient broth (Becton Dickinson) in a shak-
ing incubator at 37 C. After 48 h incubation of agar plates at 37 C
with 100 and 500 lM PFOA, in the presence or absence of rat S9
metabolic activation system (Sigma), counting of bacterial colonies
was performed. The positive controls used per plate were 0.5 lg 4-
nitroquinoline-N-oxide (Sigma) for TA98, 1 lg methyl methanesul-
fonate (Merck) for TA100 and TA102, and 50 lg methyl glyoxal
(Sigma) for TA104. Sterilized 0.5% DMSO was used as the negative
control. The mutation index (MI) was calculated as the number of
revertants in the treatment sample (induced-spontaneous)/the
number of spontaneous revertants. The concentration of PFOA
was considered as mutagenic if MI was higher than 2.0.
2.8. Data analysis
Statistical analysis was carried out using the SPSS-11.5 soft-
ware. The results were analyzed by Student’s t-test for comparing
paired samples and analysis of variance (ANOVA) with Bonferroni
or Games-Howell as post hoc tests for multiple samples. Differ-
ences were considered statistically signiﬁcant at p 6 0.05. Each
data point represents the arithmetic mean ± standard deviation
of at least three independent experiments. EC50 values (50%
Fig. 3. Cell cycle proﬁles of Vero cells exposed for 24 h to increasing concentrations
of PFOA. The values represent mean ± SD of three separate experiments. Asterisks
indicate statistically different values in treated cells compared to control cells.
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Pad Prism 4.0 using non-linear regression.
3. Results
3.1. Cytotoxic effects of PFOA
The effects of PFOA on the viability and proliferation of Vero
cells after a 24 h treatment are presented in Fig. 1. The results from
both endpoints were quite similar, showing initial toxicity at
50 lM and reaching a plateau at 200 lM. However, when cultures
were exposed to concentrations P200 lM (Student’s t-test,
p < 0.05), signiﬁcant differences were observed between the MTT
assay, which measures mitochondrial metabolism, and TPC assay
that reﬂects the total number of cells. Cell viability expressed as
EC50 was found to be 219.6 lM for MTT assay, whereas no EC50 val-
ues were obtained in Bradford assay with the PFOA concentrations
tested in the present study.
The interference of the compound with mitochondrial integrity
was veriﬁed by the morphological changes visualized under the
ﬂuorescence microscope (Fig. 2). A minor dose-dependent mito-
chondrial ﬁssion, characterized by the conversion of tubular fused
mitochondria into isolated small organelles, was observed in cells
treated with PFOA concentrations P50 lM.
To evaluate whether the reduced cell density after PFOA expo-
sure was associated with an antiproliferative effect, we conducted
a ﬂow cytometric analysis of DNA content in cells treated for 24 h
with three representative concentrations of the compound. As
shown in Fig. 3, moderate concentrations slightly, but not signiﬁ-
cantly, altered cell cycle progression when compared with un-
treated controls. However, the treatment of Vero cells withFig. 1. Dose-response curves obtained in the two cytotoxicity assays, after treat-
ment of Vero cells with increasing PFOA concentrations. The values represent m-
ean ± SD from three independent determinations. Asterisks indicate statistically
different values in treated cells compared to control cells.
Fig. 2. Representative images of Vero cells labelled with Rh-123, showing the effect of PFO
was fragmented after incubation with the compound for 24 h. Bars, 10 lm.500 lM PFOA caused signiﬁcant G0/G1 cell cycle arrest, with a con-
comitant decrease in the proportion of cells in the S and G2/M
phases.
In addition, a dose-dependent detachment of cells from culture
substrate was observed after exposure to PFOA. As apoptotic cells
rapidly lose adhesion properties in many experimental in vitro sys-
tems, ﬂuorescent microscopy was used to realize whether ﬂoating
cells exhibited signs of cell death. Vero cells, exposed to concentra-
tions P 50 lM PFOA, showed characteristic features of apoptosis
including condensed and fragmented nuclei (Fig. 4a). The propor-
tion of apoptotic cells was signiﬁcant only after exposure to
500 lM PFOA (Fig. 4b), and typically around 1–2% in the control
cell population.
3.2. Intracellular ROS production
The capacity of PFOA to cause oxidative stress in Vero cells was
evaluated by a converting reaction of DCFH-DA to DCF, which
mainly derives from the intracellular production of hydrogen per-
oxide. Cell cultures treated for 24 h with the test compound
showed an enhanced DCF ﬂuorescence over the control level, that
was signiﬁcant only at the highest concentration tested (Fig. 5).
These results indicate that PFOA stimulated the generation of reac-
tive oxygen species in a dose-dependent manner.
3.3. Ames mutagenicity test
The number of revertants induced by PFOA, with or without
metabolic activation (S9), are summarized in Table 1. According
to these results, the mutation index was calculated and PFOA did
not display mutagenic activity on the four S. typhimurium strains
used in the present study, in either of the tested concentrations.
The positive controls yielded appropriate revertant colony num-
bers, conﬁrming proper strains function.A on mitochondrial morphology. The ﬁlamentous network observed in control cells
Fig. 4. Effect of PFOA on nuclear morphology of Vero cells. (a) Fluorescence micrograph of cells, stained with Hoechst 33258 after exposure to 500 lM PFOA, showing
apoptotic nuclei (arrowheads). Bar, 5 lm. (b) Quantitative data represent the rate of apoptotic cells in cultures treated during 24 h with different PFOA doses. The values are
expressed as mean ± SD of three separate experiments. Asterisks indicate statistically different values in treated cells compared to control cells.
Fig. 5. ROS generation estimated by increase of DCF ﬂuorescence in Vero cells, after
24 h exposure to various concentrations of PFOA. The values represent mean ± SD of
three independent experiments. Asterisks indicate statistically different values in
treated cells compared to control cells.
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Over the last two decades, there has been increasing scientiﬁc
concern regarding the occurrence and dispersion of perﬂuorinated
chemicals in the environment. However, despite the epidemiolog-
ical studies, evidence relating to the toxicity of these compounds to
humans is far less conclusive. It is widely accepted that in vitro sys-
tems are useful for speciﬁc mechanistic studies and should be con-
sidered as a starting point in the assessment of in vivo toxicity.
Moreover, PFOA is metabolically inert in mammals and therefore
a particularly suitable compound for in vitro toxicity testing. In this
study, a mammalian cell line and a bacterial bioassay were em-
ployed to evaluate the cytotoxicity and mutagenic potential of per-
ﬂuorooctanoic acid.Table 1
Number of revertants induced by PFOA with or without metabolic activation (S9)
Treatment Revertant per plate
TA98 TA100
S9 +S9 S9 +S9
– 26.7 ± 7.6 70.3 ± 4.0 51.7 ± 14.0 78
Solvent control (100 lL/plate) 23.0 ± 3.5 74.3 ± 5.9 60.3 ± 3.1 72
Positive controla 227.3 ± 17.2 444.0 ± 27.8 500.0 ± 22.6 584
PFOA 100 lM 21.0 ± 1.0 63.0 ± 4.4 38.3 ± 2.5 89
PFOA 500 lM 16.0 ± 1.0 64.0 ± 6.9 47.0 ± 2.6 78
Results are shown as the mean ± SD of three independent experiments.
a 4-Nitroquinoline-N-oxide (TA98). Methylmethane–sulfonate (TA100 y TA102). MethBy comparing cell viability and proliferation data, we observed
concordance between both endpoints when cells were treated with
low PFOA doses. However, concentrations around 200 lM reduced
by 50% the ability of Vero cells to metabolize MTT, when about 70%
of cell conﬂuence was estimated using Bradford protein assay.
These ﬁrst results corroborate the well-documented inhibitory
activity of PFCs on mitochondria (Starkov and Wallace, 2002),
and were further supported by our subsequent studies. Following
PFOA treatments, Vero cells displayed fragmentation of mitochon-
drial reticulum, a morphological change consistent with defective
bioenergetic metabolism (Lyamzaev et al., 2004; Zorov et al.,
2005). There was also evidence of intracellular H2O2 generation,
expressed as a dose-dependent rise in DCF ﬂuorescence, although
the statistical analysis revealed signiﬁcant results only at the high-
er PFOA concentration tested (500 lM).
Reactive oxygen species (ROS) originating from mitochondria
may be derived through respiratory chain and normally exists in
all aerobic cells in balance with biochemical antioxidants. Alterna-
tively, dysfunctional mitochondria will produce increased levels of
ROS, creating a signiﬁcant threat for the major classes of biomole-
cules primarily lipids, proteins and DNA (Zorov et al., 2005). De-
spite the fact that reactive oxygen species have been identiﬁed as
major contributors to damage in biological systems, ROS are now
recognized as potent second messengers to trigger signal transduc-
tion pathways that regulate speciﬁc processes in virtually all cells
(Genestra, 2007). Current information indicates that ROS, in partic-
ular hydrogen peroxide promote either proliferation or cycle arrest
and subsequent cell death, depending on the intracellular levels
and/or the cell lines tested (Boonstra and Post, 2004).
The results presented in this study reveal that signiﬁcant in-
creases in the levels of intracellular H2O2 were closely linked to cell
cycle arrest at the G1 phase and induction of apoptosis. Accord-TA102 TA104
S9 +S9 S9 +S9
.0 ± 15.1 318.0 ± 26.2 382.3 ± 18.0 333.7 ± 17.0 357.7 ± 27.6
.0 ± 7.0 290.0 ± 32.0 374.3 ± 34.0 311.7 ± 23.2 330.7 ± 14.6
.7 ± 37.5 3505.7 ± 106.2 2640.3 ± 203.8 3103.3 ± 134.2 1343.0 ± 33.8
.0 ± 5.3 321.3 ± 29.0 348.7 ± 18.0 330.0 ± 22.6 458.7 ± 65.0
.3 ± 7.0 299.0 ± 19.7 363.7 ± 23.8 337.7 ± 14.0 374.3 ± 51.5
yl–glyoxal (TA104).
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cause severe oxidative stress in Vero cells. In support of this
assumption, it must be stated that other authors have previously
reported nearly identical ﬁndings, using human hepatoma HepG2
cells (Panaretakis et al., 2001; Shabalina et al., 1999). Taking into
account that PFOA triggers a common cytotoxic response in tumor-
al and non-tumoral cells, it is tempting to assume that the mode of
action of this perﬂuorinated compound is not a peculiarity among
mammalian cell types. However, further studies are needed to con-
ﬁrm this initial proposal, as well as to verify if the PFOA effects ob-
served in Vero cells are consistently found in other non-tumoral
cell lines of mammalian origin.
Another important question which remains to be resolved is
whether PFOA, in the general environments, represents a carcino-
genic risk to humans. Although some medical surveillance studies
have failed todetect any signiﬁcant associationbetweenPFOAexpo-
sure and cancer incidence, current data are limited and still under
debate (EPA, 2002). Rodent bioassays have shown that this com-
pound induces a variety of tumor types (liver, testes and pancreas),
that are in part attributed to peroxisome proliferation (Nilsson et al.,
1991). Nevertheless, the relevance tohumans of this precise effect of
PFOA, depending on the PPARa (peroxisome proliferator-activated
receptor alpha), has often been questioned (Klaunig et al., 2003).
Carcinogens are known to operate through a wide range of
mechanisms within the cells and consequently, several experimen-
tal methods can be employed in human risk assessment (Williams,
2001). Bacterial mutagenesis systems are useful tools in the ﬁrst
step of hazard identiﬁcation, since a mutagenic event is accepted
as a critical point in the initial phase of carcinogenesis (Davidson
et al., 2003). Based on this consideration, the second part of our
study was aimed to evaluate the mutagenic activity of PFOA using
the Salmonella/microsome assay, primarily developed to predict
human carcinogenicity of environmental pollutants (Maron and
Ames, 1983). Previous studies have demonstrated that PFOA was
not mutagenic in standard strains of S. typhimurium (Grifﬁth and
Long, 1980). Therefore, we decided to use alternative tester strains
to gain an insight into possible mechanisms of PFOA-induced
mutagenesis. It is worth emphasizing that TA102 and TA104
strains were included in our analysis, since they are capable to de-
tect oxidant mutagens and allow the screening of carcinogens that
were negative in standard tester strains (Levin et al., 1982).
Consistent with the preceding conclusions, Ames test revealed
negative results in all the Salmonella strains used, which corrobo-
rates that PFOA is probably not a mutagen. However, this does
not necessarily mean that this compound is not a carcinogen, since
evidence suggests that cancers result from genetic alterations as
well as from tumor promotion (Williams, 2001). Indeed, peroxi-
some proliferators, including PFOA, are in general tumor promoters
rather than initiators (Lake, 1995). Moreover, in human HepG2
cells this compound exerts genotoxic effects as a consequence of
oxidative stress and not from direct DNA damage (Yao and Zhong,
2005). Therefore, until deﬁnite evidence relating to PFOA carcino-
genicity is presented, one might assume that human tumors, if pro-
duced, could arise through epigenetic mechanisms.
Taking our results together, we conclude that PFOA, at concen-
trations several orders of magnitude above the average level de-
tected in human serum, shows no evidence of mutagenic activity
and exerts only moderate cytotoxic effects in non-tumoral mam-
malian cells. However, given the stability and extended retention
time of the compound in humans, further research is required,
since long-term health consequences of a constant and unwitting
exposure to PFOA have not yet been identiﬁed. Likewise, in view
of the fact that humans are simultaneously exposed to a large
number of environmental pollutants, the possible synergistic or
antagonistic effects between PFOA and other chemical compounds
in the body must be considered in future toxicological studies.Acknowledgements
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